EP2430443
BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.5.2010:
27.6.2018:
10720095.8
:
12.5.2030
:
BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
13.5.2010
27.6.2018
:
Pierian Holdings, Inc.:
405 Duke Drive, Suite 240, 37067, Franklin, TN, US
:
KIM, Phillip:
IrvineCalifornia, US
:
LIU, Xinjun:
San DiegoCalifornia, US
:
KIRKLAND, Richard:
San DiegoCalifornia, US
:
LEE, Tani:
San DiegoCalifornia, US
:
YBARRONDO, Belen:
San DiegoCalifornia, US
:
SINGH, Sharat:
Rancho Santa FeCalifornia, US
:
178458 P:
14.5.2009:
US
:
180787 P:
22.5.2009:
US
:
187246 P:
15.6.2009:
US
:
228522 P:
24.7.2009:
US
:
235646 P:
20.8.2009:
US
:
241804 P:
11.9.2009:
US
:
262856 P:
19.11.2009:
US
:
265227 P:
30.11.2009:
US
:
US2010034814:
13.5.2010
:
G01N 33/50, G01N 33/532, G01N 33/533, G01N 33/535, G01N 33/543, G01N 33/574